Login
Toggle navigation
Videos
Categories
Trending
CEO Jessica Skon Highlights BTS Group's Record Quarter in Discussion with Equity Analyst Rikard Engberg | Jessica Skon - CEO of BTS group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jessica Skon is the President & CEO, BTS Group
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Labor Market Imbalances: A Challenge for the Federal Reserve
00:10:00
In the Canadian Business' Portraits in Leadership program, a reflection on leadership underscores the importance of relationships and understanding others' needs for mutual benefit and growth.|Jean-Louis Servranckx is President and Chief Executive Office
00:10:00
Understanding Business Valuation and Buyer Types
00:10:00
Navigating Market Uncertainty Amid Global Events
00:10:00
Embark on an inspiring journey with Marc Parent, President and CEO of CAE, whose early experiences with the Air Cadets shaped his remarkable career, while CAE fosters youth interest in aviation through its "From Cadets to CAE" initiative.|Jason Goodfriend
00:10:00
Safeguarding Wealth: Leveraging Precious Metals for Stability in Volatile Markets | Financial Insights on Portfolio Diversification
00:10:00
They invest and support founders from seed until the later stages|Peter Sobiloff,Managing Director,Insight Partners
00:10:00
Understanding Your Balance Sheet: A Simple Guide
00:10:00
Inca One Gold Reports Near Record Q1 Performance
00:10:00
Female Founders are shaping China's Innovation Landscape with|Xu Ying,General Partner,Vertex Ventures
00:10:00
Joe Bergera, CEO of Iteris, Discusses Future of Smart Mobility Infrastructure Management | Joe Bergera - President and Chief Executive Officer of Iteris, Inc.
00:10:00
Bloomberg Markets: Insights from JoAnn Price on Diverse Managers - Fairview Capital